Christopher Blakeley
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
-
- PARP inhibition in cancer therapy
- Neutropenia and Cancer Infections
Papers in
- Co-authors
- Nicoletta Colombo (10 shared papers)Giovanni Scambia (4 shared papers)Sandro Pignata (4 shared papers)Radosław Mądry (6 shared papers)Andrés Poveda (6 shared papers)Kristina Lindemann (5 shared papers)Ana Oaknin (4 shared papers)Isabel Bover (1 shared paper)
- Journals
- Annals of Oncology (6 papers)Gynecologic Oncology (3 papers)Journal of Clinical Oncology (3 papers)European Journal of Cancer (1 paper)Future Oncology (1 paper)
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
Christopher Blakeley
13 papers receiving 206 citations
Peers
Comparison fields: 5 of 31
- Reproductive Medicine 112
- Oncology 166
- Genetics 113
- Cancer Research 21
- Immunology 22
Countries citing papers authored by Christopher Blakeley
This map shows the geographic impact of Christopher Blakeley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Blakeley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Blakeley more than expected).
Fields of papers citing papers by Christopher Blakeley
This network shows the impact of papers produced by Christopher Blakeley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Blakeley. The network helps show where Christopher Blakeley may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Blakeley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 68 | |
| 2 | 2021 | 42 | |
| 3 | 2022 | 29 | |
| 4 | 2019 | 14 | |
| 5 | 2017 | 13 | |
| 6 | 2023 | 12 | |
| 7 | 2019 | 11 | |
| 8 | 2020 | 7 | |
| 9 | 2016 | 4 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2018 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 0 |
About Christopher Blakeley
Christopher Blakeley is a scholar working on Oncology, Genetics, Reproductive Medicine, Molecular Biology and Pharmacology, having authored 15 papers that have together received 210 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (11 papers), PARP inhibition in cancer therapy (11 papers), Ovarian cancer diagnosis and treatment (10 papers), CRISPR and Genetic Engineering (3 papers), Neutropenia and Cancer Infections (3 papers), Blood disorders and treatments (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Reproductive Medicine (112 citations), Oncology (166 citations), Genetics (113 citations), Cancer Research (21 citations) and Immunology (22 citations). Christopher Blakeley has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Nicoletta Colombo, Giovanni Scambia, Sandro Pignata, Radosław Mądry, Andrés Poveda, Kristina Lindemann, Ana Oaknin, Isabel Bover, James V. Fiorica and Sharad Ghamande. Their work appears in journals such as Annals of Oncology, Gynecologic Oncology, Journal of Clinical Oncology, European Journal of Cancer and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.